| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
18,203 |
17,323 |
$8.33M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,644 |
8,023 |
$4.08M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
28,631 |
27,746 |
$3.95M |
| 76819 |
Fetal biophysical profile; without non-stress testing |
4,585 |
2,339 |
$712K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
3,278 |
1,960 |
$569K |
| 80053 |
Comprehensive metabolic panel |
18,770 |
16,950 |
$491K |
| 76820 |
|
4,425 |
2,191 |
$414K |
| 80050 |
General health panel |
914 |
905 |
$396K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,751 |
17,844 |
$289K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
16,247 |
13,613 |
$254K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,628 |
1,567 |
$219K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
5,976 |
5,819 |
$140K |
| 71045 |
Radiologic examination, chest; single view |
7,275 |
6,918 |
$135K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,955 |
1,033 |
$121K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,054 |
961 |
$112K |
| 81001 |
|
12,894 |
12,045 |
$98K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,747 |
5,116 |
$91K |
| 80061 |
Lipid panel |
1,570 |
1,546 |
$88K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
265 |
246 |
$83K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
699 |
664 |
$82K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,589 |
6,149 |
$75K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,039 |
9,770 |
$71K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,762 |
4,634 |
$69K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,718 |
6,530 |
$66K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,276 |
3,808 |
$64K |
| 93976 |
|
609 |
545 |
$64K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,974 |
2,644 |
$61K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,952 |
1,794 |
$53K |
| 84439 |
|
1,026 |
998 |
$50K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,302 |
1,281 |
$36K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
323 |
271 |
$31K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
748 |
725 |
$29K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
504 |
456 |
$27K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
85 |
79 |
$24K |
| 84484 |
|
2,376 |
2,002 |
$21K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
119 |
108 |
$21K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
967 |
887 |
$17K |
| 90715 |
|
193 |
190 |
$17K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,338 |
4,918 |
$16K |
| 83690 |
|
1,831 |
1,691 |
$16K |
| 87070 |
|
2,841 |
2,766 |
$15K |
| 81025 |
|
1,582 |
1,485 |
$14K |
| 83525 |
|
311 |
305 |
$14K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
209 |
136 |
$13K |
| 84702 |
|
1,013 |
870 |
$13K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,896 |
1,076 |
$11K |
| 87807 |
|
1,657 |
1,621 |
$11K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,572 |
2,233 |
$11K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
289 |
275 |
$9K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
132 |
77 |
$6K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
823 |
642 |
$6K |
| 84703 |
|
472 |
445 |
$6K |
| 83880 |
|
288 |
250 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
83 |
81 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
359 |
331 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
365 |
309 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
178 |
163 |
$5K |
| 82607 |
|
108 |
106 |
$5K |
| 81003 |
|
2,715 |
2,561 |
$4K |
| 87077 |
|
679 |
625 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
126 |
121 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,150 |
906 |
$4K |
| 82728 |
|
103 |
103 |
$4K |
| 76827 |
|
30 |
26 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
620 |
493 |
$4K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
87 |
77 |
$4K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
41 |
39 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
502 |
346 |
$3K |
| 85610 |
|
1,397 |
1,235 |
$3K |
| 87186 |
|
441 |
399 |
$3K |
| 83735 |
|
859 |
677 |
$3K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
598 |
582 |
$3K |
| 85730 |
|
835 |
756 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
725 |
716 |
$2K |
| 80076 |
|
30 |
30 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
194 |
190 |
$2K |
| 74018 |
|
131 |
129 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
405 |
365 |
$2K |
| 86900 |
|
705 |
655 |
$2K |
| 86901 |
|
751 |
698 |
$2K |
| 85027 |
|
499 |
398 |
$1K |
| 0002A |
|
676 |
652 |
$1K |
| 99001 |
|
126 |
123 |
$1K |
| 87631 |
|
13 |
13 |
$1K |
| 76801 |
|
13 |
12 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
134 |
120 |
$1K |
| 0001A |
|
705 |
672 |
$978.97 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
12 |
12 |
$868.35 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
772 |
724 |
$806.99 |
| 85651 |
|
15 |
15 |
$771.92 |
| 82947 |
|
28 |
26 |
$737.51 |
| 82962 |
|
1,577 |
729 |
$679.92 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
12 |
12 |
$668.34 |
| 87806 |
|
12 |
12 |
$602.03 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
81 |
70 |
$489.88 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
74 |
64 |
$489.42 |
| 90686 |
|
12 |
12 |
$483.20 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,532 |
1,391 |
$469.90 |
| 83605 |
|
108 |
81 |
$436.72 |
| 84100 |
|
243 |
177 |
$389.60 |
| G0008 |
Administration of influenza virus vaccine |
27 |
27 |
$342.60 |
| A9270 |
Non-covered item or service |
1,415 |
787 |
$66.06 |
| J2704 |
Injection, propofol, 10 mg |
322 |
299 |
$60.16 |
| 96376 |
|
19 |
13 |
$31.90 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
14 |
13 |
$27.10 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
156 |
147 |
$21.39 |
| 36416 |
|
51 |
49 |
$0.00 |